Danaher Co. (NYSE:DHR) Shares Purchased by Blue Whale Capital LLP

Blue Whale Capital LLP lifted its holdings in Danaher Co. (NYSE:DHRFree Report) by 67.9% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 201,500 shares of the conglomerate’s stock after purchasing an additional 81,500 shares during the period. Danaher makes up 6.0% of Blue Whale Capital LLP’s holdings, making the stock its 8th biggest holding. Blue Whale Capital LLP’s holdings in Danaher were worth $46,615,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Nicholas Hoffman & Company LLC. grew its stake in shares of Danaher by 2.3% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after purchasing an additional 43 shares during the period. Los Angeles Capital Management LLC grew its stake in Danaher by 1.3% in the 4th quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock valued at $803,000 after acquiring an additional 43 shares during the last quarter. Berger Financial Group Inc grew its stake in Danaher by 1.7% in the 4th quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock valued at $582,000 after acquiring an additional 43 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its stake in Danaher by 1.0% in the 4th quarter. Pinnacle Wealth Planning Services Inc. now owns 4,329 shares of the conglomerate’s stock valued at $1,001,000 after acquiring an additional 43 shares during the last quarter. Finally, Drive Wealth Management LLC grew its stake in Danaher by 3.1% in the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock valued at $344,000 after acquiring an additional 44 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 1.2 %

Shares of DHR stock traded up $3.14 during trading hours on Monday, hitting $259.94. 312,205 shares of the company were exchanged, compared to its average volume of 2,700,723. The firm has a market cap of $192.53 billion, a PE ratio of 43.53, a PEG ratio of 3.93 and a beta of 0.85. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $268.98. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. The firm has a fifty day moving average of $250.39 and a 200 day moving average of $241.27.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The company’s revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the firm posted $2.36 EPS. Analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 annualized dividend and a yield of 0.42%. Danaher’s payout ratio is 18.31%.

Insider Activity at Danaher

In related news, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total value of $2,386,325.00. Following the transaction, the chief executive officer now owns 106,990 shares in the company, valued at $28,352,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Danaher news, Director Alan G. Spoon sold 708 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the sale, the director now owns 116,202 shares of the company’s stock, valued at $28,304,483.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Rainer Blair sold 9,005 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the completion of the sale, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 148,783 shares of company stock worth $37,536,717. Company insiders own 10.90% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of research reports. HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and increased their price objective for the company from $250.00 to $280.00 in a research note on Wednesday, April 17th. TD Cowen increased their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Barclays increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 24th. Bank of America raised their price target on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. Finally, Citigroup raised their price target on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $267.31.

Get Our Latest Analysis on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.